Usage of Long-Acting Muscarinic Antagonists and Biologics as Add-on Therapy for Patients in the United States with Moderate-to-Severe Asthma.

Objective: Many asthma patients remain uncontrolled on inhaled corticosteroids (ICS) and long-acting beta agonists (LABAs), but guidance for selecting add-on therapies, including long-acting muscar...